Under the Bill, the drugs scheduled are for topical application only and may be used by an optometrist only in the course of his or her professional practice; they cannot be taken orally or injected. In addition, these drugs are not for resale and may not be given to the patient. This will enable optometrists to carry out their jobs fully and to the best of their ability. They will be able to look after a patient up to the point of facilitating medical treatment of injury or disease of the eye.